Volume 66 Received 5 April 2010 | |||||||||||
| |||||||||||
aCollege of Chemistry, Tianjin Normal University, 393 Binshuixi Road, Xiqing District, Tianjin 300387, People's Republic of China,bNankai High School, 100 Sima Road, Nankai District, Tianjin 300100, People's Republic of China, and cState Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, People's Republic of China
Correspondence e-mail: hsxyxhz@mail.tjnu.edu.cn, zyq8165@nankai.edu.cn
The title compound, C20H19N3O, exists in a keto-enamine tautomeric form. The pyrazolone ring makes dihedral angles of 20.52 (10) and 77.73 (5)° with the two phenyl rings and an intramolecular N-H
O hydrogen bond occurs. A weak intermolecular C-H
O hydrogen bond is observed in the crystal structure. The allyl group is disordered over two positions, with site-occupancy factors of 0.533 (5) and 0.467 (5).
For the analgesic activity of metal complexes with 1-phenyl-3-methyl-4-benzoylpyrazolon-5-one, see: Li et al. (1997
); Liu et al. (1980
); Zhou et al. (1999
). For related structures, see: Bao et al. (2004
); Sun et al. (2007
); Zhu et al. (2005
).
|
|
| ||||||||||||||||||||||
Data collection: CrystalClear (Rigaku, 2009
); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: CrystalStructure (Rigaku, 2009
); software used to prepare material for publication: CrystalStructure.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IS2538 ).
The authors gratefully acknowledge the financial support of the National Natural Science Foundation of China (grant No. 20772066).
Bao, F., Lü, X.-Q., Qiao, Y.-Q., Wu, Q. & Ng, S. W. (2004). Acta Cryst. E60, o2191-o2192.
![[details]](../../../../../../e/graphics/details.gif)
Li, J.-Z., Yu, W.-J. & Du, X.-Y. (1997). Chin. J. Appl. Chem. 14, 98-100. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Liu, J.-M., Yang, R.-D. & Ma, T.-R. (1980). Chem. J. Chin. Univ. 1, 23-29. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Rigaku (2009). CrystalClear and CrystalStrcuture. Rigaku Corporation, Tokyo, Japan.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Sun, Y.-F., Li, J.-K., Wu, R.-T. & Zheng, Z.-B. (2007). Acta Cryst. E63, o2176-o2177.
![[details]](../../../../../../e/graphics/details.gif)
Zhou, Y.-P., Yang, Zh.-Y., Yu, H.-J. & Yang, R.-D. (1999). Chin. J. Appl. Chem. 16, 37-41. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Zhu, H., Zhang, X., Song, Y., Xu, H. & Dong, M. (2005). Acta Cryst. E61, o2387-o2388.
![[details]](../../../../../../e/graphics/details.gif)